Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | Unknown | — |
The patient received the second dose of Rabipur on day 8 also reported as delay of 12 hours; Case reference number US-BN-2025-001325 is a spontaneous case initially received from a consumer via agency (reference number: USBAV25-1830) on 28-Jul-2025 and concerns a male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On an unspecified date also reported as on the 18th, the patient received the first dose of RabAvert vaccine along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown) at an unknown dose, route, or site of administration, for the indication of pre-exposure to rabies (pre-trip). On an unspecified date also reported as on Day 8, an unknown amount of time from the first dose (also reported as a delay of 12 hours), the patient received the second dose of RabAvert vaccine along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown) at an unknown dose, route, or site of administration (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any of adverse event due to RabAvert. No further information was provided.; Reporter's Comments: This case concerns a male patient of unspecified age, who received the second dose of RabAvert vaccine on day 8 day from the first dose for the indication of pre-exposure to rabies (pre-trip), which is considered as 'inappropriate schedule of vaccine administered'. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any of adverse event due to RabAvert. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerns a male patient of unspecified age, who received the second dose of RabAvert vaccine on day 8 day from the first dose for the indication of pre-exposure to rabies (pre-trip), which is considered as 'inappropriate schedule of vaccine administered'. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any of adverse event due to RabAvert. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE